Peptide Nucleic Acid as Therapeutic Agent
With a repeating N-(2-aminoethyl)-glycine peptide backbone coupled to purine and pyrimidine nucleobases via a linker, PNA are synthetic analogues of DNA. PNA-based technology has received a lot of interest as a viable method for gene modification due to the unique qualities of PNA, including resistance to enzymatic digestion, increased bio stability, and excellent hybridization affinity toward DNA and RNA. However, inadequate intracellular absorption presents a significant obstacle to the use of PNA. To improve PNA delivery and ensure that it reaches the appropriate spot, some solutions have been devised
Related Conference of Peptide Nucleic Acid as Therapeutic Agent
Peptide Nucleic Acid as Therapeutic Agent Conference Speakers
Recommended Sessions
- A New Approach to Determining the Nucleic Acid Sequence
- Function of Nucleic Acid
- Types of RNA
- Artificial Nucleic Acid
- DNA Damage and Repair
- Effect of Nucleic Acid on Protein Synthesis
- Enzymes for Nucleic Acids
- Infectious Disease
- Molecular Biology
- Molecular Structure of Nucleic Acid
- Nucleic Acid as a Genetic Material
- Nucleic Acid Bases
- Nucleic Acid Probes
- Nucleic Acid Recognition
- Peptide Nucleic Acid as Therapeutic Agent
- Recombinant DNA Technology
- RNA Processing and Protein Synthesis
- Thermodynamics of Nucleic Acids
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Imaging and Super-Resolution Techniques - Structural Biology 2026 (Spain)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomolecular Dynamics and Allostery - Structural Biology 2026 (Spain)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Structural Biology and Artificial Intelligence - Structural Biology 2026 (Spain)
- Cryo-Electron Microscopy (Cryo-EM) - Structural Biology 2026 (Spain)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Integrative and Hybrid Structural Biology - Structural Biology 2026 (Spain)
- Membrane Protein Structure and Dynamics - Structural Biology 2026 (Spain)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Nuclear Magnetic Resonance (NMR) Spectroscopy - Structural Biology 2026 (Spain)
- Protein Engineering and Synthetic Biology - Structural Biology 2026 (Spain)
- Protein Structure and Function - Structural Biology 2026 (Spain)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Structural Basis of Genetic and Metabolic Disorders - Structural Biology 2026 (Spain)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Biology in Drug Discovery - Structural Biology 2026 (Spain)
- Structural Genomics and Proteomics - Structural Biology 2026 (Spain)
- Structural Immunology - Structural Biology 2026 (Spain)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Virus Structure and Host Interactions - Structural Biology 2026 (Spain)
- X-ray Crystallography and Diffraction Methods - Structural Biology 2026 (Spain)
